Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.

Nature medicine | Sep 24, 1999

CD39, or vascular adenosine triphosphate diphosphohydrolase, has been considered an important inhibitor of platelet activation. Unexpectedly, cd39-deficient mice had prolonged bleeding times with minimally perturbed coagulation parameters. Platelet interactions with injured mesenteric vasculature were considerably reduced in vivo and purified mutant platelets failed to aggregate to standard agonists in vitro. This platelet hypofunction was reversible and associated with purinergic type P2Y1 receptor desensitization. In keeping with deficient vascular protective mechanisms, fibrin deposition was found at multiple organ sites in cd39-deficient mice and in transplanted cardiac grafts. Our data indicate a dual role for adenosine triphosphate diphosphohydrolase in modulating hemostasis and thrombotic reactions.

Pubmed ID: 10470077 RIS Download

Mesh terms: Adenosine Triphosphatases | Animals | Antigens, CD | Apyrase | Arterioles | Bleeding Time | Blood Coagulation | Blood Platelets | Cells, Cultured | Endothelium, Vascular | Female | Fibrin | Gene Deletion | Graft Rejection | Heart Transplantation | Hemostasis | Male | Mesentery | Mice | Mice, Knockout | Platelet Aggregation | Rats | Receptors, Purinergic P2 | Receptors, Purinergic P2Y1 | Thromboplastin | Thrombosis

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, Id: HL41002
  • Agency: NHLBI NIH HHS, Id: HL57307
  • Agency: PHS HHS, Id: P01-41484

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.